Found 14 results
Author Title [ Type(Asc)] Year
Filters: Author is Graham, B  [Clear All Filters]
Journal Article
J. Casazza, Bowman, K., Adzaku, S., Smith, E., Enama, M., Bailer, R., Price, D., Gostick, E., Gordon, I., Ambrozak, D., Nason, M., Roederer, M., Andrews, C., Maldarelli, F., Wiegand, A., ,, Ledgerwood, J., Graham, B., Koup, R., and Team, T. V. R. C. 101 St, “Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire”, J Infect Dis, vol. 207, pp. 1829-1840, 2013.
L. Chang, Dowd, K., Mendoza, F., Saunders, J., Sitar, S., Plummer, S., Yamshchikov, G., Sarwar, U., Hu, Z., Enama, M., Bailer, R., Koup, R., Schwartz, R., Akahata, W., Nabel, G., Mascola, J., Pierson, T., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 311 St, “Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial”, Lancet, vol. 384, pp. 2046-2052, 2014.
W. Jaoko, Karita, E., Kayitenkore, K., Omosa-Manyonyi, G., Allen, S., Than, S., Adams, E., Graham, B., Koup, R., Bailer, R., Smith, C., Dally, L., Farah, B., Anzala, O., Muvunyi, C., Bizimana, J., Tarragona-Fiol, T., Bergin, P., Hayes, P., Ho, M., Loughran, K., and Komaroff, W., “Safety and Immunogenicity Study of Multiclade HIV-1 Adeno-Viral Vector Vaccine Alone or as Boost Following a Multiclade HIV-1 DNA Vaccine in Africa”, PLoS ONE, vol. 5, p. e12873, 2010.
U. Sarwar, Costner, P., Enama, M., Berkowitz, N., Hu, Z., Hendel, C., Sitar, S., Plummer, S., Mulangu, S., Bailer, R., Koup, R., Mascola, J., Nabel, G., Sullivan, N., Graham, B., Ledgerwood, J. E., and Team, T. V. R. C. 206 St, “Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial”, J Infect Dis, vol. 211, pp. 549-557, 2015.
R. Seder, Chang, L., Enama, M., Zephir, K., Sarwar, U. N., Gordon, I., Holman, L., James, E., Billingsley, P., Gunasekera, A., Richman, A., Chakravarty, S., Manoj, A., Velmurugan, S., Li, M., ,, Sim, B., Ledgerwood, J., Graham, B., Hoffman, S., and Team, T. V. R. C. 312 St, “Protection Against Malaria by Intravenous Immunization With A Non-Replicating Sporozoite Vaccine”, Science, vol. 341, pp. 1359-1365, 2013.
M. Crank, Gordon, I., Yamshchikov, G., Sitar, S., Hu, Z., Enama, M., Holman, L., Bailer, R., Pearce, M., Koup, R., Mascola, J., Nabel, G., Tumpey, T., Schwartz, R., Graham, B., Ledgerwood, J., and Team, T. V. R. C. 308 St, “Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults”, PLoS One, vol. 10, p. e0123969, 2015.
A. T. Catanzaro, Koup, R. A., Roederer, M., Bailer, R. T., Enama, M. E., Moodie, Z., Gu, L., Martin, J. E., Novik, L., Chakrabarti, B. K., Butman, B., Gall, J., King, C., Andrews, C., Sheets, R., Gomez, P., Mascola, J., Nabel, G., Graham, B., and Team, T. Vaccine Re, “Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector”, J Infect Dis, vol. 194, pp. 1638-1649, 2006.
B. Graham, McElrath, M., Keefer, M., Rybczyk, K., Berger, D., Weinhold, K., Ottinger, J., Ferarri, G., Montefiori, D., Stablein, D., Smith, C., Ginsberg, R., Eldridge, J., Duerr, A., Fast, P., Haynes, B., and Group, T. A. I. D. S. Vacci, “Immunization With Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, But Causes Sterile Abscesses and Unacceptable Reactogenicity”, PLoS One, vol. 5, p. e11995, 2010.
L. Corey, McElrath, M. J., Weinhold, K., Matthews, T., Stablein, D., Graham, B., Keefer, M., Schwartz, D., Gorse, G., and Group, theA. I. D. S. Vacci, “Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type1 envelope with a combination vaccine regimen”, J Infec Dis, vol. 177, pp. 301-9, 1998.
L. Corey, McElrath, M. J., Weinhold, K., Matthews, T., Stablein, D., Graham, B., Keefer, M., Schwartz, D., and Gorse, G., “Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.”, J Infect Dis, vol. 177, no. 2, pp. 301-9, 1998.
J. Ledgerwood, DeZure, A., Stanley, D., Novik, L., Enama, M., Berkowitz, N., Hu, Z., Joshi, G., Ploquin, A., Sitar, S., Gordon, I., Plummer, S., Holman, L., ,, Mascola, J., Koup, R., Sullivan, N., Graham, B., and Team, T. V. R. C. 207 St, “Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report”, N Engl J Med, 2014.
Conference Proceedings
R. Belshe, Bolognesi, D., Clements, M., Corey, L., Fast, P., Graham, B., Keefer, M., Mestecky, J., Mulligan, M., Stablein, D., and Group, A. I. D. S. Vaccine Cl, “Progress in HIV-1 Vaccine Development”. Washington DC, 1995.
Conference Paper
J. E. Ledgerwood, Yamschikov, G., Enama, M. E., Sarwar, U. N., Bailer, R. T., Larkin, B., Bellamy, A. R., Anderson, E. L., Bernstein, D. I., Creech, B., Keyserling, H., Spearman, P., Wright, P., and Graham, B., “VRC 702: A Multicenter Phase 1 Study of Seasonal Influenza DNA Vaccine Prime Followed by the Trivalent Inactivated Vaccine (TIV) Compared to TIV-TIV in Children and Adolescents Ages 6-17 Years”, in 2014 Annual Conference on Vaccine Research, Bethesda, MD, 2014.
W. Jaoko, Kayitenkore, K., G Manyonyi, O., Karita, E., Schmidt, C., Fast, P., Komaroff, W., Cooper, A., Boaz, M., Gilmour, J., Dally, L., Ho, M., Smith, C., and Graham, B., “Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.